These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 1476186
1. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Gomez-Sanchez EP, Gomez-Sanchez CE. Am J Physiol; 1992 Dec; 263(6):E1125-30. PubMed ID: 1476186 [Abstract] [Full Text] [Related]
3. Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CR. Endocrinology; 1989 Aug; 125(2):1046-53. PubMed ID: 2752963 [Abstract] [Full Text] [Related]
4. Regulation of sodium-potassium adenosine triphosphate subunit gene expression by corticosteroids and 11 beta-hydroxysteroid dehydrogenase activity. Whorwood CB, Ricketts ML, Stewart PM. Endocrinology; 1994 Sep; 135(3):901-10. PubMed ID: 8070385 [Abstract] [Full Text] [Related]
5. Role of glucocorticoid in the development of glycyrrhizin-induced hypertension. Kageyama Y, Suzuki H, Saruta T. Clin Exp Hypertens; 1994 Nov; 16(6):761-78. PubMed ID: 7858558 [Abstract] [Full Text] [Related]
6. Effect of central amiloride infusion on mineralocorticoid hypertension. Gomez-Sanchez EP, Gomez-Sanchez CE. Am J Physiol; 1994 Nov; 267(5 Pt 1):E754-8. PubMed ID: 7977727 [Abstract] [Full Text] [Related]
7. 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Zhang ZH, Kang YM, Yu Y, Wei SG, Schmidt TJ, Johnson AK, Felder RB. Hypertension; 2006 Jul; 48(1):127-33. PubMed ID: 16717146 [Abstract] [Full Text] [Related]
8. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Walker BR, Edwards CR. Endocrinol Metab Clin North Am; 1994 Jun; 23(2):359-77. PubMed ID: 8070427 [Abstract] [Full Text] [Related]
9. What is the role of the central nervous system in mineralocorticoid hypertension? Gómez Sánchez EP. Am J Hypertens; 1991 Apr; 4(4 Pt 1):374-81. PubMed ID: 1647798 [Abstract] [Full Text] [Related]
10. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation. Young MJ, Moussa L, Dilley R, Funder JW. Endocrinology; 2003 Mar; 144(3):1121-5. PubMed ID: 12586788 [Abstract] [Full Text] [Related]
11. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Gomez-Sanchez EP, Fort C, Thwaites D. Am J Physiol; 1992 Jan; 262(1 Pt 1):E96-9. PubMed ID: 1310219 [Abstract] [Full Text] [Related]
12. The mechanism of mineralocorticoid action of carbenoxolone. Armanini D, Karbowiak I, Krozowski Z, Funder JW, Adam WR. Endocrinology; 1982 Nov; 111(5):1683-6. PubMed ID: 6290195 [Abstract] [Full Text] [Related]
13. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. van den Berg DT, de Kloet ER, van Dijken HH, de Jong W. Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978 [Abstract] [Full Text] [Related]
14. Licorice, computer-based analyses of dehydrogenase sequences, and the regulation of steroid and prostaglandin action. Baker ME, Fanestil DD. Mol Cell Endocrinol; 1991 Jun; 78(1-2):C99-102. PubMed ID: 1834493 [No Abstract] [Full Text] [Related]
15. Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta. Walker BR, Sang KS, Williams BC, Edwards CR. J Hypertens; 1994 Jan; 12(1):33-9. PubMed ID: 8157942 [Abstract] [Full Text] [Related]
16. Inhibition of Streptomyces hydrogenans 3 alpha,20 beta-hydroxysteroid dehydrogenase by licorice-derived compounds and crystallization of an enzyme-cofactor-inhibitor complex. Ghosh D, Erman M, Pangborn W, Duax WL, Baker ME. J Steroid Biochem Mol Biol; 1992 Sep; 42(8):849-53. PubMed ID: 1525045 [Abstract] [Full Text] [Related]
17. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action. Funder JW, Pearce PT, Myles K, Roy LP. FASEB J; 1990 Nov; 4(14):3234-8. PubMed ID: 2172062 [Abstract] [Full Text] [Related]
18. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate. Cosmetic Ingredient Review Expert PanelCosmetic Ingredient Review, Washington DC 20036, USA.. Int J Toxicol; 2007 Nov; 26 Suppl 2():79-112. PubMed ID: 17613133 [Abstract] [Full Text] [Related]
19. Differential inhibition of 11 beta-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. Jellinck PH, Monder C, McEwen BS, Sakai RR. J Steroid Biochem Mol Biol; 1993 Aug; 46(2):209-13. PubMed ID: 8664169 [Abstract] [Full Text] [Related]
20. 11-Dehydrocorticosterone in the presence of carbenoxolone is a more potent sodium retainer than corticosterone. Souness GW, Morris DJ. Steroids; 1993 Jan; 58(1):24-8. PubMed ID: 8430442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]